Ascendance Biotechnology Overview
- Year Founded
-
2015

- Status
-
Acquired/Merged
- Employees
-
2

- Latest Deal Type
-
M&A
- Investors
-
1
Ascendance Biotechnology General Information
Description
Developer of stem cell derived products intended to offer unique cell-based assays. The company's services include application-directed, cellular micro-patterning drug and chemical screening, predictive analysis and basic research, enabling pharmaceutical companies to get basic stem cell research through clinical manufacturing using products that are translatable to the clinic.
Contact Information
Website
www.ascendancebio.comCorporate Office
- 200 Boston Avenue
- Suite 1500
- Medford, MA 02155
- United States
Corporate Office
- 200 Boston Avenue
- Suite 1500
- Medford, MA 02155
- United States
Ascendance Biotechnology Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 27-Mar-2018 | Completed | Generating Revenue | |||
2. Angel (individual) | 17-May-2016 | Completed | Startup | |||
1. Angel (individual) | 21-Dec-2015 | $650K | $650K | Completed | Startup |
Ascendance Biotechnology Comparisons
Industry
Financing
Details
Ascendance Biotechnology Competitors (16)
One of Ascendance Biotechnology’s 16 competitors is TransGenex Nanobiotech, a Formerly Accelerator/Incubator backed company based in Tampa, FL.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
TransGenex Nanobiotech | Formerly Accelerator/Incubator backed | Tampa, FL | ||||
Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
Cellesce | Formerly VC-backed | Cardiff, United Kingdom | ||||
InSphero | Venture Capital-Backed | Schlieren, Switzerland | ||||
Lonza Group | Corporation | Basel, Switzerland |
Ascendance Biotechnology Patents
Ascendance Biotechnology Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-10696949-B2 | Systems and methods for canine liver modeling | Active | 26-Jan-2015 | ||
US-20160369238-A1 | Systems and methods for canine liver modeling | Active | 26-Jan-2015 | ||
US-20160363584-A1 | Systems and methods for studying inflammation-drug interactions | Inactive | 12-Mar-2012 | ||
AU-2012207545-B2 | Systems and methods for micro-contact stamping | Active | 21-Jan-2011 | ||
CA-2825274-A1 | Systems and methods for micro-contact stamping | Active | 21-Jan-2011 | C12M33/02 |
Ascendance Biotechnology Signals
Ascendance Biotechnology Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AgeX Therapeutics | Corporation | Minority |
Ascendance Biotechnology Acquisitions (1)
Ascendance Biotechnology’s most recent deal was a Merger of Equals with Hepregen. The deal was made on 06-Nov-2015.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Hepregen | 06-Nov-2015 | Merger of Equals | Biotechnology |
Ascendance Biotechnology FAQs
-
When was Ascendance Biotechnology founded?
Ascendance Biotechnology was founded in 2015.
-
Where is Ascendance Biotechnology headquartered?
Ascendance Biotechnology is headquartered in Medford, MA.
-
What is the size of Ascendance Biotechnology?
Ascendance Biotechnology has 2 total employees.
-
What industry is Ascendance Biotechnology in?
Ascendance Biotechnology’s primary industry is Biotechnology.
-
Is Ascendance Biotechnology a private or public company?
Ascendance Biotechnology is a Private company.
-
What is Ascendance Biotechnology’s current revenue?
The current revenue for Ascendance Biotechnology is
. -
How much funding has Ascendance Biotechnology raised over time?
Ascendance Biotechnology has raised $880K.
-
Who are Ascendance Biotechnology’s investors?
AgeX Therapeutics has invested in Ascendance Biotechnology.
-
Who are Ascendance Biotechnology’s competitors?
TransGenex Nanobiotech, Aspect Biosystems, Cellesce, InSphero, and Lonza Group are some of the 16 competitors of Ascendance Biotechnology.
-
When was Ascendance Biotechnology acquired?
Ascendance Biotechnology was acquired on 27-Mar-2018.
-
Who acquired Ascendance Biotechnology?
Ascendance Biotechnology was acquired by IVT Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »